Hi there,

Can you donate $10 per month to support Democracy Now!’s independent journalism all year long? Since our very first broadcast in 1996, we’ve refused to take government or corporate funding, because nothing is more important to us than our editorial independence—especially in this unprecedented election year. When Democracy Now! covers war and peace or the climate crisis, we’re not brought to you by the weapons manufacturers or the oil, gas, coal or nuclear companies. Our journalism is powered by YOU. But that means we can’t do our work without your support. Right now, a generous donor will DOUBLE your gift, which means your $10 donation this month will be worth $20 to Democracy Now! Please do your part right now. We’re all in this together. Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Donate

Ex-GOP Congressman to Head Pharmaceutical Lobby

HeadlineDec 16, 2004

The country’s main pharmaceutical lobbying group has hired departing Republican Congressman Billy Tauzin as its new chief with an annual salary of around $2 million. Up until February the Louisiana politician served as chairman of the House committee with jurisdiction over drug-industry issues. He was the principal author of the new Medicare drug law which was strongly backed by the pharmeceutical industry. In other lobbying news, former Republican Congressman James Greenwood of Pennsylvania is soon to become the head of the Biotechnology Industry Organization. Greenwood is the former head of the Energy and Commerce investigative subcommittee.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top